Skip to main content

Find Clinical Trials

Home
Conditions
Skin Neoplasms

Clinical trial condition

Skin Neoplasms

Explore clinical trials studying Skin Neoplasms. Study availability and eligibility vary by location and protocol.

2,111 public trials 360 recruiting studies

Refine in advanced search Browse all conditions

Skin Neoplasms trial results

Completed

Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors

NCT04096638

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +16 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Fecal Microbiota Transplant (FMT) in Melanoma Patients

NCT03341143

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma

NCT01436656

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +23 more
Locations: H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View all 24 locations

View Trial Details

Completed

Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma

NCT04091217

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Beijing Cancer Center; Renal Cancer And Melanoma Department. Beijing, China

Fujian Provincial Cancer Hospital Fuzhou, China

Zhejiang Cancer Hospital Zhejiang, China

View Trial Details

Completed

Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients

NCT05615883

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy

View Trial Details

Completed

Interest of Tumor Replicates in Avian Embryo to Model Therapeutic Effects of BRAFi/MEKi in BRAF Mutated Melanoma

NCT04039672

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Service de Dermatologie, Centre hospitalier Lyon Sud, HCL Pierre-Bénite, France

View Trial Details

Completed

Safety and Avoidance of Futile Excisions Through Skin Tele-triage

NCT05982600

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +11 more
Locations: Gustav Gede Nervil Brønshøj, Copenhagen, Denmark

View Trial Details

Completed

CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma

NCT02027935

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma

NCT01740557

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +12 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Study to Evaluate Safety and Therapeutic Activity of RO6874281 in Combination with Pembrolizumab, in Participants with Advanced or Metastatic Melanoma

NCT03875079

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Yale University New Haven, Connecticut, United States

University of Iowa Iowa City, Iowa, United States

Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View all 23 locations

View Trial Details